期刊
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
卷 21, 期 6, 页码 955-965出版社
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2009060662
关键词
-
资金
- National Institutes of Health [R01 DK58413, T32 DK072922, R01 GM067958]
- National Kidney Foundation
Agonists of the sphingosine-1-phosphate receptor (S1PR) attenuate kidney ischemia-reperfusion injury (IRI). Previous studies suggested that S1P(1)R-induced lymphopenia mediates this protective effect, but lymphocyte-independent mechanisms could also contribute. Here, we investigated the effects of Si PR agonists on kidney IRI in mice that lack T and B lymphocytes (Rag-1 knockout mice). Administration of the nonselective S1PR agonist FTY720 or the selective S1P(1)R agonist SEW2871 reduced injury in both Rag-1 knockout and wild-type mice. In vitro, SEW2871 significantly attenuated LPS- or hypoxia/reoxygenation-induced apoptosis in cultured mouse proximal tubule epithelial cells, supporting a direct protective effect of S1P(1)R agonists via mitogen-activated protein kinase and/or Akt pathways. S1P(1)Rs in the proximal tubule mediated IRI in vivo as well: Mice deficient in proximal tubule S1P(1)Rs experienced a greater decline in renal function after IRI than control mice and their kidneys were no longer protected by SEW2871 administration. In summary, S1PRs in the proximal tubule are necessary for stress-induced cell survival, and S1P(1)R agonists are renoprotective via direct effects on the tubule cells. Selective agonists of S1P(1)Rs may hold therapeutic potential for the prevention and treatment of acute kidney injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据